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ABSTRACT
Plasma cell cheilitis (PCC) is an inflammatory disorder of unknown etiology that affects the lip. It is characterized 
histologically by a dense infiltrate of plasma cells with a variety of clinical features. The response to different therapeutic 
modalities is controversial, especially regarding the effectiveness of corticosteroids. We present a case of a 56-year-old 
Caucasian man with a painful ulcerated and crusted area in the lower lip, resembling a squamous cell carcinoma or 
actinic cheilitis. Topical corticosteroid was used for one week, which resulted in partial regression and motivated a biopsy. 
The histological examination provided the diagnosis of PCC. The patient has been disease-free for six months. We also 
provide a discussion on the criteria of differential diagnosis and management of this rare condition. 
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INTRODUCTION
Plasma cell cheilitis (PCC) is a rare site-specific type 
of plasma cell mucositis reported in older adults, with 
higher prevalence in men.1,2 The lesion is presented 
as circumscribed erosive or erythematous plaques or 
patches on the labial mucosa, predominantly on the 
lower lip.1,3,4 Histopathologically, PCC consists of a 
proliferation of mature plasma cells distributed as a 
dense band-like subepithelial infiltrate.2,5,6 Additionally, 
the epithelium may present dyskeratosis, intercellular 
edema, erosion or ulceration, hyperkeratosis, and 
vacuolar degeneration in the conjunctival-epithelial 
junction.2,7 When these clinical and microscopic 
findings are located intraorally, they are called plasma 
cell mucositis.8-11 Different therapeutic approaches 
have been performed, but the outcomes remain 
paradoxical.5 We present a case of PCC clinically similar 
to lip squamous cell carcinoma or actinic cheilitis, but 
responsive to topical corticosteroid.
CASE REPORT
A 56-year-old Caucasian male farmer sought the 
Oral Diagnosis Clinic complaining of a pricking pain 
in the lower lip where he had an unhealed wound 
for about six years. His medical history included 
hypertension and diabetes and there was no history 
of drinking or smoking. However, the patient reported 
being exposed daily to the sun without UV protection. 
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The examination showed a 3-cm ulcerated and crusted 
area on the lower lip (Figures 1A and 1B). There were 
no clinical changes in the intraoral examination. 
The clinical findings and the patient’s occupation led 
to the diagnosis of lip squamous cell carcinoma or 
actinic cheilitis.
An incisional biopsy could not be performed 
at the first appointment due to the patient’s high 
blood pressure (200/120 mmHg). The topical use of 
0.1% triamcinolone acetonide cream was prescribed 
until the next appointment. After seven days, the 
patient returned to the clinic with significant clinical 
improvement. The incisional biopsy was performed 
under local anesthesia and the tissue specimen was 
sent to histopathological analysis. The tissue sections 
showed parakeratotic stratum corneum with ulcerated 
areas, showing in the lamina propria a dense sheet-like 
infiltrate predominantly of mature plasma cells, some 
Figure 2. Photomicrograph of the biopsy specimen. A – Hyperplastic and parakeratinized stratified squamous 
epithelium with dense infiltrate of plasma cells in the lamina propria (Hematoxylin-eosin, 20X); B – Presence 
of a band-like infiltrate of plasma cells. (Hematoxylin-eosin, 100X); C – Monomorphic mature plasma cells. 
(Hematoxylin-eosin, 400X); D – Presence of Russel body (arrow) (Hematoxylin-eosin, 200X).
Figure 1. Clinical aspect of lips. A – Absence of upper lip changes; B – Well-marked ulcerated and crusted area on 
the lower lip.
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lymphocytes, few eosinophils, and sparse Russell bodies 
(Figures 2A-D). The plasma cells infiltrated the entire 
connective tissue up to the minor salivary glands. It is 
worth noting the absence of cellular atypia, pleomorphic 
figures, and mitotic activity. Immunohistochemistry 
to kappa and lambda immunoglobulin light chains 
showed polyclonal plasma cells, with a predominance 
of lambda (Figures 3A and 3B).
Considering the clinical and histopathological 
findings and a negative serological test for syphilis, 
PCC was diagnosed. The topical corticosteroid was 
suspended after 10 days of use. Lip balm cream and 
sunscreen were prescribed and the lesion completely 
regressed 35 days after the biopsy (Figure 4).
There was no recurrence after six months of 
follow-up and the administration of lip balm and 
sunscreen was maintained.
DISCUSSION
Plasma cell cheilitis (PCC) is a type of mucositis 
enriched with plasma cells. Plasma cell mucositis was 
first described in 1952 by Zoon12 and it has been 
identified in distinct anatomical areas and in other 
mucosae such as glans and vulva.8 Plasmacytosis 
circumorificialis and plasmacytosis mucosae are 
other terms used in the literature.13 Although PCC is 
mentioned in the literature as a rare disorder, the data 
on its incidence is scarce.
The PCC affects more commonly the lower 
l ip of men, with the peak of incidence in the 
elderly.1,2 The clinical features are characterized 
by erosive, ulcerative, fissured, bleeding, crusting, 
and erythematous plaques or patches on the labial 
mucosa,4,5,14 usually accompanied by the symptom of 
Figure 3. Photomicrograph of the biopsy specimen. Plasma cells showing positivity for both lambda (A) and kappa 
(B) (Immunohistochemistry, 200X).
Figure 4. Clinical aspect of lower lip during follow-up. A, B – Complete regression of ulcerated and bleeding area 
35 days after the biopsy.
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pricking.2 The clinical evaluation of PCC frequently 
leads to an initial misdiagnosis, which requires biopsy 
and additional investigations.11 The clinical differential 
diagnoses are actinic cheilitis, allergic contact cheilitis, 
exfoliative cheilitis, granulomatous cheilitis, lichen 
planus, and lip squamous cell carcinoma.5 Considering 
that PCC is rarely considered a differential diagnosis 
in the clinical routine, our provisional clinical diagnosis 
(actinic cheilitis or lip squamous cell carcinoma) was 
based on the most frequent ones for the clinical 
features of the patient. The histological diagnosis is 
based on the identification of a sheet-like infiltration 
of monomorphic mature plasma cells without anaplasia 
or prominent nucleoli, and Russel bodies are found 
occasionally.2,5,6 The clinicopathologic features of the 
current case were consistent with PCC.
The etiology of PCC remains unknown. One theory 
speculates that inflammatory cells such as T cells and 
macrophages affect the growth and differentiation 
of B cells.4,5,15,16 Another theory holds that PCC might 
be a response to exogenous factors such as trauma 
and solar damage.2,6 We assume that solar damage 
might have triggered PCC, considering our patient is 
a farmer who is constantly exposed to the sun without 
UV protection. In addition, neoplastic plasma cell 
disorders are composed mainly of monoclonal cells, 
whereas inflammatory ones consist of polyclonal cells.17 
Therefore, considering that oral plasma cell mucositis 
is composed of polyclonal plasma cells,12 PCC might 
be considered a benign inflammatory condition. 
A predominance of kappa immunoglobulin light chain 
was mentioned in nine out of 13 cases evaluated 
previously,2 which contrasts with the higher levels of 
lambda positivity of cells in the present case.
Considering the histological character of PCC 
diagnosis,14 the microscopic differential diagnosis may 
include a variety of lesions such as allergic contact 
cheilitis, secondary syphilis (mucous patches - erosions 
or ulcers with an erythematous margin), actinic cheilitis, 
squamous cell carcinoma, cheilitis granulomatosa, and 
plasmacytoma.7,8,18 These lesions may be excluded 
depending on the histomorphology. Allergic contact 
cheilitis shows inflammatory infiltrates mainly consisting 
of lymphocytes, Langerhans cells, macrophages, and 
eosinophils rather than plasma cells.19 Our case showed 
a consistent infiltrate of mature plasma cells and the 
patient did not report allergies or sensitivities to a 
specific substance. The histopathological features of 
syphilis are inflammatory infiltrates containing plasma 
cells, lymphocytes, and macrophages, usually with 
a perivascular distribution.20 The present case was 
not marked by a perivascular location of plasma cells 
and a serological screening ruled out syphilis. Actinic 
cheilitis is represented by hyperkeratosis with epithelial 
hyperplasia or atrophy, acanthosis, solar elastosis, 
chronic inflammatory infiltrate, vasodilatation, and it 
may present dysplasia,21-23 which were not detected in 
our case. Lip squamous cell carcinoma shows variable 
degrees of squamous differentiation featured by the 
invasion of the underlying stroma,24 which was not 
observed in our findings. Cheilitis granulomatosa 
shows noncaseating granulomatous inflammation,25 
which was not found in the present case. Plasmacytoma 
is a rare malignant neoplasm that usually affects the 
mandible when occurring in the oral cavity,26 and 
it is characterized by the proliferation of atypical 
monoclonal plasma cells.20 Our biopsy specimen did 
not show cellular atypia, pleomorphic figures, and 
mitotic activity, and the cells were polyclonal, thus 
ruling out the diagnosis of plasmacytoma.
Different therapeutic approaches to PCC have 
been proposed, such as surgical excision, radiation 
therapy, electrocauterization, cryotherapy, topical 
application of fusidic acid, systemic and topical 
corticosteroids, administration of systemic griseofulvin, 
and immunomodulatory agents.1,5,8,18,27-32 Nevertheless, 
the outcome with topical corticosteroid therapy varies 
from poor15 to successful1. Such sliding response to 
topical corticosteroid may be explained by epithelial 
width, as distinct results of topical corticosteroid 
treatment between atrophic, mild acanthotic, and 
marked acanthotic variants have been reported.8,33 
Our patient presented clinical improvement with topical 
steroid treatment. Thus, we assume that the presence 
of ulcerative lesions increased the effectiveness of 
topical corticosteroid treatment.
In addition, it is worth emphasizing that disorders 
featured by plasma cell mucositis, considered as benign 
entities, have a favorable prognosis.11 The absence 
of recurrence in the present case contributes to this 
concept. Moreover, to the best of our knowledge, PCC 
has a benign clinical behavior, as the development of 
malignant neoplasia from PCC has not been reported 
yet.
In summary, PCC is an uncommon disorder in 
the clinical routine, which may present some similar 
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clinical and histopathological findings with different 
conditions. Biopsy is required to confirm the diagnosis. 
Clinicians and pathologists should consider PCC 
when evaluating lesions on the lip, and corticosteroid 
treatment should be considered when detecting such 
condition.
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